Crinetics Pharmaceuticals Announces Shareholder Approval for Merger
Acquiring Company
Crinetics Pharmaceuticals
Acquired Company
Unknown
San DiegoBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
On August 28, 2026, Crinetics Pharmaceuticals, Inc. held a special meeting of shareholders to vote on proposals related to a merger. A significant number of shares voted in favor of the merger at the meeting. This reflects strong shareholder support for the transaction.
Don't miss Crinetics Pharmaceuticals's next move
Get an email the moment Crinetics Pharmaceuticals makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Unknown?
Unknown was acquired by Crinetics Pharmaceuticals, based in San Diego. The deal was reported on August 28, 2026. Crinetics Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors. Crinetics Pharmaceuticals is publicly traded (CRNX) and operates in Biotechnology.
When did Crinetics Pharmaceuticals acquire Unknown?
Crinetics Pharmaceuticals's acquisition of Unknown was reported on August 28, 2026. On August 28, 2026, Crinetics Pharmaceuticals, Inc. held a special meeting of shareholders to vote on proposals related to a merger. A significant number of shares voted in favor of the merger at the meeting. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Unknown do?
Unknown is the company acquired in this transaction. It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.